Ischemia-induced hyperglycemia: Consequences, neuroendocrine regulation, and a role for RAGE

Hormones and Behavior

Volumn 62, Issue 3, 2012, Pages 280-285

  Weil, Zachary M ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

Corticosterone; Hyperglycemia; Insulin; Ischemia; RAGE

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; AMYLOID BETA PROTEIN; HIGH MOBILITY GROUP B1 PROTEIN; INSULIN; LACTIC ACID; PROTEIN S 100;

BRAIN ISCHEMIA; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISEASE SEVERITY; GLUCOSE HOMEOSTASIS; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; MEDIATOR RELEASE; MORBIDITY; MORTALITY; NEUROPATHOLOGY; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; BLOOD GLUCOSE; BRAIN ISCHEMIA; HUMANS; HYPERGLYCEMIA; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; RECEPTORS, IMMUNOLOGIC;

EID: 84866761990     PISSN: 0018506X     EISSN: 10956867     Source Type: Journal    
DOI: 10.1016/j.yhbeh.2012.04.001     Document Type: Review

References (87)

1. Aljada A., Friedman J., Ghanim H., Mohanty P., Hofmeyer D., Chaudhuri A., Dandona P. Glucose ingestion induces an increase in intranuclear nuclear factor kappaB, a fall in cellular inhibitor kappaB, and an increase in tumor necrosis factor alpha messenger RNA by mononuclear cells in healthy human subjects. Metabolism 2006, 55:1177-1185.
2. Anderson R.E., Tan W.K., Martin H.S., Meyer F.B. Effects of glucose and PaO2 modulation on cortical intracellular acidosis, NADH redox state, and infarction in the ischemic penumbra. Stroke 1999, 30:160-170.
3. Arabi Y.M., Dehbi M., Rishu A.H., Baturcam E., Kahoul S.H., Brits R.J., Naidu B., Bouchama A. sRAGE in diabetic and non-diabetic critically ill patients: effects of intensive insulin therapy. Crit. Care 2011, 15:R203.
4. Atochin D.N., Wang A., Liu V.W., Critchlow J.D., Dantas A.P., Looft-Wilson R., Murata T., Salomone S., Shin H.K., Ayata C., Moskowitz M.A., Michel T., Sessa W.C., Huang P.L. The phosphorylation state of eNOS modulates vascular reactivity and outcome of cerebral ischemia in vivo. J. Clin. Invest. 2007, 117:1961-1967.
5. Bopp C., Bierhaus A., Hofer S., Bouchon A., Nawroth P.P., Martin E., Weigand M.A. Bench-to-bedside review: the inflammation-perpetuating pattern-recognition receptor RAGE as a therapeutic target in sepsis. Crit. Care 2008, 12:201.
6. Bruno A., Biller J., Adams H.P., Clarke W.R., Woolson R.F., Williams L.S., Hansen M.D. Acute blood glucose level and outcome from ischemic stroke. Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators. Neurology 1999, 52:280-284.
7. Bucciarelli L.G., Kaneko M., Ananthakrishnan R., Harja E., Lee L.K., Hwang Y.C., Lerner S., Bakr S., Li Q., Lu Y., Song F., Qu W., Gomez T., Zou Y.S., Yan S.F., Schmidt A.M., Ramasamy R. Receptor for advanced-glycation end products: key modulator of myocardial ischemic injury. Circulation 2006, 113:1226-1234.
8. Capes S.E., Hunt D., Malmberg K., Pathak P., Gerstein H.C. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients - a systematic overview. Stroke 2001, 32:2426-2432.
9. Cassady C.J., Phillis J.W., O'Regan M.H. Further studies on the effects of topical lactate on amino acid efflux from the ischemic rat cortex. Brain Res. 2001, 901:30-37.
10. Chavakis T., Bierhaus A., Al-Fakhri N., Schneider D., Witte S., Linn T., Nagashima M., Morser J., Arnold B., Preissner K.T., Nawroth P.P. The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: a novel pathway for inflammatory cell recruitment. J. Exp. Med. 2003, 198:1507-1515.
11. Christensen H., Boysen G., Johannesen H.H. Serum-cortisol reflects severity and mortality in acute stroke. J. Neurol. Sci. 2004, 217:175-180.
12. Craft T.K., Zhang N., Glasper E.R., Hurn P.D., Devries A.C. Neonatal factors influence adult stroke outcome. Psychoneuroendocrinology 2006, 31:601-613.
13. Demchuk A.M., Morgenstern L.B., Krieger D.W., Linda Chi T., Hu W., Wein T.H., Hardy R.J., Grotta J.C., Buchan A.M. Serum glucose level and diabetes predict tissue plasminogen activator-related intracerebral hemorrhage in acute ischemic stroke. Stroke 1999, 30:34-39.
14. Desouza C., Gilling L., Fonseca V. Management of the insulin resistance syndrome. Curr. Diab. Rep. 2001, 1:140-147.
15. DeVries A.C., Joh H.D., Bernard O., Hattori K., Hurn P.D., Traystman R.J., Alkayed N.J. Social stress exacerbates stroke outcome by suppressing Bcl-2 expression. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:11824-11828.
16. Dinkel K., MacPherson A., Sapolsky R.M. Novel glucocorticoid effects on acute inflammation in the CNS. J. Neurochem. 2003, 84:705-716.
17. Fassbender K., Schmidt R., Mossner R., Daffertshofer M., Hennerici M. Pattern of activation of the hypothalamic-pituitary-adrenal axis in acute stroke. Relation to acute confusional state, extent of brain damage, and clinical outcome. Stroke 1994, 25:1105-1108.
18. Feinstein R., Kanety H., Papa M.Z., Lunenfeld B., Karasik A. Tumor necrosis factor-alpha suppresses insulin-induced tyrosine phosphorylation of insulin receptor and its substrates. J. Biol. Chem. 1993, 268:26055-26058.
19. Finfer S., Chittock D.R., Su S.Y., Blair D., Foster D., Dhingra V., Bellomo R., Cook D., Dodek P., Henderson W.R., Hebert P.C., Heritier S., Heyland D.K., McArthur C., McDonald E., Mitchell I., Myburgh J.A., Norton R., Potter J., Robinson B.G., Ronco J.J. Intensive versus conventional glucose control in critically ill patients. N. Engl. J. Med. 2009, 360:1283-1297.
20. Fogelholm R., Murros K., Rissanen A., Avikainen S. Admission blood glucose and short term survival in primary intracerebral haemorrhage: a population based study. J. Neurol. Neurosurg. Psychiatry 2005, 76:349-353.
21. Gisselsson L., Smith M.L., Siesjo B.K. Hyperglycemia and focal brain ischemia. J. Cereb. Blood Flow Metab. 1999, 19:288-297.
22. Goldstein R.S., Gallowitsch-Puerta M., Yang L., Rosas-Ballina M., Huston J.M., Czura C.J., Lee D.C., Ward M.F., Bruchfeld A.N., Wang H., Lesser M.L., Church A.L., Litroff A.H., Sama A.E., Tracey K.J. Elevated high-mobility group box 1 levels in patients with cerebral and myocardial ischemia. Shock 2006, 25:571-574.
23. Hacke W., Kaste M., Fieschi C., Toni D., Lesaffre E., von Kummer R., Boysen G., Bluhmki E., Hoxter G., Mahagne M.H., et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA 1995, 274:1017-1025.
24. Hagiwara S., Iwasaka H., Hasegawa A., Koga H., Noguchi T. Effects of hyperglycemia and insulin therapy on high mobility group box 1 in endotoxin-induced acute lung injury in a rat model. Crit. Care Med. 2008, 36:2407-2413.
25. Hanford L.E., Enghild J.J., Valnickova Z., Petersen S.V., Schaefer L.M., Schaefer T.M., Reinhart T.A., Oury T.D. Purification and characterization of mouse soluble receptor for advanced glycation end products (sRAGE). J. Biol. Chem. 2004, 279:50019-50024.
26. Harris S.B., Gunion M.W., Rosenthal M.J., Walford R.L. Serum glucose, glucose tolerance, corticosterone and free fatty acids during aging in energy restricted mice. Mech. Ageing Dev. 1994, 73:209-221.
27. Hassid B.G., Nair M.N., Ducruet A.F., Otten M.L., Komotar R.J., Pinsky D.J., Schmidt A.M., Yan S.F., Connolly E.S. Neuronal RAGE expression modulates severity of injury following transient focal cerebral ischemia. J. Clin. Neurosci. 2009, 16:302-306.
28. Heuschmann P.U., Kolominsky-Rabas P.L., Misselwitz B., Hermanek P., Leffmann C., Janzen R.W.C., Rother J., Buecker-Nott H., Berger K., Grp G.S.R.S. Predictors of in-hospital mortality and attributable risks of death after ischemic stroke - the German Stroke Registers Study Group. Arch. Intern. Med. 2004, 164:1761-1768.
29. Hofmann M.A., Drury S., Fu C., Qu W., Taguchi A., Lu Y., Avila C., Kambham N., Bierhaus A., Nawroth P., Neurath M.F., Slattery T., Beach D., McClary J., Nagashima M., Morser J., Stern D., Schmidt A.M. RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 1999, 97:889-901.
30. Hofmann M.A., Drury S., Hudson B.I., Gleason M.R., Qu W., Lu Y., Lalla E., Chitnis S., Monteiro J., Stickland M.H., Bucciarelli L.G., Moser B., Moxley G., Itescu S., Grant P.J., Gregersen P.K., Stern D.M., Schmidt A.M. RAGE and arthritis: the G82S polymorphism amplifies the inflammatory response. Genes Immun. 2002, 3:123-135.
31. Hori O., Brett J., Slattery T., Cao R., Zhang J., Chen J.X., Nagashima M., Lundh E.R., Vijay S., Nitecki D., et al. The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system. J. Biol. Chem. 1995, 270:25752-25761.
32. Hotamisligil G.S., Shargill N.S., Spiegelman B.M. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993, 259:87-91.
33. Huang Z., Huang P.L., Ma J., Meng W., Ayata C., Fishman M.C., Moskowitz M.A. Enlarged infarcts in endothelial nitric oxide synthase knockout mice are attenuated by nitro-l-arginine. J. Cereb. Blood Flow Metab. 1996, 16:981-987.
34. Huang J.S., Guh J.Y., Chen H.C., Hung W.C., Lai Y.H., Chuang L.Y. Role of receptor for advanced glycation end-product (RAGE) and the JAK/STAT-signaling pathway in AGE-induced collagen production in NRK-49F cells. J. Cell. Biochem. 2001, 81:102-113.
35. Johnston K.C., Hall C.E., Kissela B.M., Bleck T.P., Conaway M.R. Glucose Regulation in Acute Stroke Patients (GRASP) trial: a randomized pilot trial. Stroke 2009, 40:3804-3809.
36. Kamide T., Kitao Y., Takeichi T., Okada A., Mohri H., Schmidt A.M., Kawano T., Munesue S., Yamamoto Y., Yamamoto H., Hamada J., Hori O. RAGE mediates vascular injury and inflammation after global cerebral ischemia. Neurochem. Int. 2012, 60:220-228.
37. Kannel W.B., McGee D.L. Diabetes and cardiovascular disease. The Framingham study. JAMA 1979, 241:2035-2038.
38. Kase C.S., O'Neal A.M., Fisher M., Girgis G.N., Ordia J.I. Intracranial hemorrhage after use of tissue plasminogen activator for coronary thrombolysis. Ann. Intern. Med. 1990, 112:17-21.
39. Kendall D.M., Harmel A.P. The metabolic syndrome, type 2 diabetes, and cardiovascular disease: understanding the role of insulin resistance. Am. J. Manag. Care 2002, 8:S635-S653. (quiz S654-637).
40. Kimura K., Iguchi Y., Inoue T., Shibazaki K., Matsumoto N., Kobayashi K., Yamashita S. Hyperglycemia independently increases the risk of early death in acute spontaneous intracerebral hemorrhage. J. Neurol. Sci. 2007, 255:90-94.
41. LaManna J.C., Griffith J.K., Cordisco B.R., Lin C.W., Lust W.D. Intracellular pH in rat brain in vivo and in brain slices. Can. J. Physiol. Pharmacol. 1992, 70:S269-S277. (Suppl.).
42. Lansberg M.G., Thijs V.N., Bammer R., Kemp S., Wijman C.A., Marks M.P., Albers G.W. Risk factors of symptomatic intracerebral hemorrhage after tPA therapy for acute stroke. Stroke 2007, 38:2275-2278.
43. Lapar D.J., Sharma A.K., Hajzus V.A., Zhao Y., Lau C.L., French B.A., Kron I.L., Laubach V.E. Acute hyperglycemic exacerbation of lung ischemia-reperfusion injury is mediated by RAGE signaling. Am. J. Respir. Cell Mol. Biol. 2011, 46:299-305.
44. Lawrence M.S., Sapolsky R.M. Glucocorticoids accelerate ATP loss following metabolic insults in cultured hippocampal neurons. Brain Res. 1994, 646:303-306.
45. Li L., Messina J.L. Acute insulin resistance following injury. Trends Endocrinol. Metab. 2009, 20:429-435.
46. Li J., Schmidt A.M. Characterization and functional analysis of the promoter of RAGE, the receptor for advanced glycation end products. J. Biol. Chem. 1997, 272:16498-16506.
47. Li L., Thompson L.H., Zhao L., Messina J.L. Tissue-specific difference in the molecular mechanisms for the development of acute insulin resistance after injury. Endocrinology 2009, 150:24-32.
48. Marklund N., Peltonen M., Nilsson T.K., Olsson T. Low and high circulating cortisol levels predict mortality and cognitive dysfunction early after stroke. J. Intern. Med. 2004, 256:15-21.
49. Martin A., Rojas S., Chamorro A., Falcon C., Bargallo N., Planas A.M. Why does acute hyperglycemia worsen the outcome of transient focal cerebral ischemia? Role of corticosteroids, inflammation, and protein O-glycosylation. Stroke 2006, 37:1288-1295.
50. Melamed E. Reactive hyperglycemia in patients with acute stroke. J. Neurol. Sci. 1976, 29:267-275.
51. Mortel K.F., Meyer J.S., Sims P.A., Mcclintic K. Diabetes-mellitus as a risk factor for stroke. South. Med. J. 1990, 83:904-911.
52. Muhammad S., Barakat W., Stoyanov S., Murikinati S., Yang H., Tracey K.J., Bendszus M., Rossetti G., Nawroth P.P., Bierhaus A., Schwaninger M. The HMGB1 receptor RAGE mediates ischemic brain damage. J. Neurosci. 2008, 28:12023-12031.
53. Murros K., Fogelholm R., Kettunen S., Vuorela A.L., Valve J. Blood glucose, glycosylated haemoglobin, and outcome of ischemic brain infarction. J. Neurol. Sci. 1992, 111:59-64.
54. Neeper M., Schmidt A.M., Brett J., Yan S.D., Wang F., Pan Y.C., Elliston K., Stern D., Shaw A. Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J. Biol. Chem. 1992, 267:14998-15004.
55. OuYang Y.B., Mellergard P., Kristian T., Kristianova V., Siesjo B.K. Influence of acid-base changes on the intracellular calcium concentration of neurons in primary culture. Exp. Brain Res. 1994, 101:265-271.
56. Payne R.S., Tseng M.T., Schurr A. The glucose paradox of cerebral ischemia: evidence for corticosterone involvement. Brain Res. 2003, 971:9-17.
57. Pellerin L., Magistretti P.J. Glutamate uptake into astrocytes stimulates aerobic glycolysis: a mechanism coupling neuronal activity to glucose utilization. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:10625-10629.
58. Poppe A.Y., Majumdar S.R., Jeerakathil T., Ghali W., Buchan A.M., Hill M.D. Admission hyperglycemia predicts a worse outcome in stroke patients treated with intravenous thrombolysis. Diabetes Care 2009, 32:617-622.
59. Raman K.G., Sappington P.L., Yang R., Levy R.M., Prince J.M., Liu S., Watkins S.K., Schmidt A.M., Billiar T.R., Fink M.P. The role of RAGE in the pathogenesis of intestinal barrier dysfunction after hemorrhagic shock. Am. J. Physiol. Gastrointest. Liver Physiol. 2006, 291:G556-G565.
60. Ramasamy R., Vannucci S.J., Yan S.S., Herold K., Yan S.F., Schmidt A.M. Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation. Glycobiology 2005, 15:16R-28R.
61. Ramasamy R., Yan S.F., Schmidt A.M. Advanced glycation endproducts: from precursors to RAGE: round and round we go. Amino Acids 2012, 42:1151-1161.
62. Raucci A., Cugusi S., Antonelli A., Barabino S.M., Monti L., Bierhaus A., Reiss K., Saftig P., Bianchi M.E. A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10). FASEB J. 2008, 22:3716-3727.
63. Rehncrona S., Hauge H.N., Siesjo B.K. Enhancement of iron-catalyzed free radical formation by acidosis in brain homogenates: differences in effect by lactic acid and CO2. J. Cereb. Blood Flow Metab. 1989, 9:65-70.
64. Rojas A., Romay S., Gonzalez D., Herrera B., Delgado R., Otero K. Regulation of endothelial nitric oxide synthase expression by albumin-derived advanced glycosylation end products. Circ. Res. 2000, 86:E50-E54.
65. Sapolsky R.M., Pulsinelli W.A. Glucocorticoids potentiate ischemic injury to neurons: therapeutic implications. Science 1985, 229:1397-1400.
66. Schiekofer S., Andrassy M., Chen J., Rudofsky G., Schneider J., Wendt T., Stefan N., Humpert P., Fritsche A., Stumvoll M., Schleicher E., Haring H.U., Nawroth P.P., Bierhaus A. Acute hyperglycemia causes intracellular formation of CML and activation of ras, p42/44 MAPK, and nuclear factor kappaB in PBMCs. Diabetes 2003, 52:621-633.
67. Schmidt A.M., Vianna M., Gerlach M., Brett J., Ryan J., Kao J., Esposito C., Hegarty H., Hurley W., Clauss M., et al. Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface. J. Biol. Chem. 1992, 267:14987-14997.
68. Schmidt A.M., Hori O., Cao R., Yan S.D., Brett J., Wautier J.L., Ogawa S., Kuwabara K., Matsumoto M., Stern D. RAGE: a novel cellular receptor for advanced glycation end products. Diabetes 1996, 45(Suppl. 3):S77-S80.
69. Schmidt A.M., Du Yan S., Yan S.F., Stern D.M. The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. J. Clin. Invest. 2001, 108:949-955.
70. Schurr A. Lactate, glucose and energy metabolism in the ischemic brain (Review). Int. J. Mol. Med. 2002, 10:131-136.
71. Schurr A., Payne R.S., Miller J.J., Tseng M.T. Preischemic hyperglycemia-aggravated damage: evidence that lactate utilization is beneficial and glucose-induced corticosterone release is detrimental. J. Neurosci. Res. 2001, 66:782-789.
72. Siesjo B.K., Bendek G., Koide T., Westerberg E., Wieloch T. Influence of acidosis on lipid peroxidation in brain tissues in vitro. J. Cereb. Blood Flow Metab. 1985, 5:253-258.
73. Soop A., Sunden-Cullberg J., Albert J., Hallstrom L., Treutiger C.J., Sollevi A. Adenosine infusion attenuates soluble RAGE in endotoxin-induced inflammation in human volunteers. Acta Physiol (Oxf.) 2009, 197:47-53.
74. Soro-Paavonen A., Watson A.M., Li J., Paavonen K., Koitka A., Calkin A.C., Barit D., Coughlan M.T., Drew B.G., Lancaster G.I., Thomas M., Forbes J.M., Nawroth P.P., Bierhaus A., Cooper M.E., Jandeleit-Dahm K.A. Receptor for advanced glycation end products (RAGE) deficiency attenuates the development of atherosclerosis in diabetes. Diabetes 2008, 57:2461-2469.
75. Sternberg D.I., Gowda R., Mehra D., Qu W., Weinberg A., Twaddell W., Sarkar J., Wallace A., Hudson B., D'Ovidio F., Arcasoy S., Ramasamy R., D'Armiento J., Schmidt A.M., Sonett J.R. Blockade of receptor for advanced glycation end product attenuates pulmonary reperfusion injury in mice. J. Thorac. Cardiovasc. Surg. 2008, 136:1576-1585.
76. Thornalley P.J. Cell activation by glycated proteins. AGE receptors, receptor recognition factors and functional classification of AGEs. Cell. Mol. Biol. (Noisy-le-Grand) 1998, 44:1013-1023.
77. Toth C., Rong L.L., Yang C., Martinez J., Song F., Ramji N., Brussee V., Liu W., Durand J., Nguyen M.D., Schmidt A.M., Zochodne D.W. Receptor for advanced glycation end products (RAGEs) and experimental diabetic neuropathy. Diabetes 2008, 57:1002-1017.
78. Turnbull A.V., Rivier C. Regulation of the HPA axis by cytokines. Brain Behav. Immun. 1995, 9:253-275.
79. Virgin C.E., Ha T.P., Packan D.R., Tombaugh G.C., Yang S.H., Horner H.C., Sapolsky R.M. Glucocorticoids inhibit glucose transport and glutamate uptake in hippocampal astrocytes: implications for glucocorticoid neurotoxicity. J. Neurochem. 1991, 57:1422-1428.
80. Weir C.J., Murray G.D., Dyker A.G., Lees K.R. Is hyperglycaemia an independent predictor of poor outcome after acute stroke? Results of a long-term follow up study. BMJ 1997, 314:1303-1306.
81. Welsh F.A., Sims R.E., McKee A.E. Effect of glucose on recovery of energy metabolism following hypoxia-oligemia in mouse brain: dose-dependence and carbohydrate specificity. J. Cereb. Blood Flow Metab. 1983, 3:486-492.
82. Xu B., Chibber R., Ruggiero D., Kohner E., Ritter J., Ferro A. Impairment of vascular endothelial nitric oxide synthase activity by advanced glycation end products. FASEB J. 2003, 17:1289-1291.
83. Yan S.D., Schmidt A.M., Anderson G.M., Zhang J., Brett J., Zou Y.S., Pinsky D., Stern D. Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. J. Biol. Chem. 1994, 269:9889-9897.
84. Yan S.S., Wu Z.Y., Zhang H.P., Furtado G., Chen X., Yan S.F., Schmidt A.M., Brown C., Stern A., LaFaille J., Chess L., Stern D.M., Jiang H. Suppression of experimental autoimmune encephalomyelitis by selective blockade of encephalitogenic T-cell infiltration of the central nervous system. Nat. Med. 2003, 9:287-293.
85. Yang Z., Laubach V.E., French B.A., Kron I.L. Acute hyperglycemia enhances oxidative stress and exacerbates myocardial infarction by activating nicotinamide adenine dinucleotide phosphate oxidase during reperfusion. J. Thorac. Cardiovasc. Surg. 2009, 137:723-729.
86. Yusim A., Ajilore O., Bliss T., Sapolsky R. Glucocorticoids exacerbate insult-induced declines in metabolism in selectively vulnerable hippocampal cell fields. Brain Res. 2000, 870:109-117.
87. Zeng S., Dun H., Ippagunta N., Rosario R., Zhang Q.Y., Lefkowitch J., Yan S.F., Schmidt A.M., Emond J.C. Receptor for advanced glycation end product (RAGE)-dependent modulation of early growth response-1 in hepatic ischemia/reperfusion injury. J. Hepatol. 2009, 50:929-936.